Page last updated: 2024-08-23

raloxifene hydrochloride and Cardiovascular Stroke

raloxifene hydrochloride has been researched along with Cardiovascular Stroke in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	7 (77.78)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lerman, J; Siseles, N	1
Vestergaard, P	1
Anderson, PW; Barrett-Connor, E; Baygani, SK; Collins, P; Grady, D; Kornitzer, M; Mosca, L; Moscarelli, E; Sashegyi, A; Wenger, NK	1
Bofilis, E; Iliodromitis, EK; Kremastinos, DT; Kyriakides, ZS; Sbarouni, E	1
Wenger, NK	1
Anderson, PW; Barrett-Connor, E; Collins, P; Grady, D; Helterbrand, JD; Kornitzer, M; Mosca, L; Moscarelli, E; Paul, S; Wenger, NK; Wright, TJ	1
Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Node, K; Ogita, H; Sanada, S; Takashima, S	1

Reviews

2 review(s) available for raloxifene hydrochloride and Cardiovascular Stroke

Article	Year
[Hormone replacement therapy and cardiovascular prevention. Where are we now?]. Medicina, 2008, Volume: 68, Issue:3 Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Myocardial Infarction; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Women's Health	2008
[Menopausal hormone therapy and cardiovascular disease]. Revista espanola de cardiologia, 2006, Volume: 59, Issue:10 Topics: Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Coronary Disease; Electrocardiography; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Heart Rate; Humans; Life Style; Mammography; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Progestins; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Stroke; Time Factors	2006

Article

Year

[Hormone replacement therapy and cardiovascular prevention. Where are we now?].

Medicina, 2008, Volume: 68, Issue:3

Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Myocardial Infarction; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Women's Health

2008

[Menopausal hormone therapy and cardiovascular disease].

Revista espanola de cardiologia, 2006, Volume: 59, Issue:10

Topics: Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Coronary Disease; Electrocardiography; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Heart Rate; Humans; Life Style; Mammography; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Progestins; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Stroke; Time Factors

2006

Trials

1 trial(s) available for raloxifene hydrochloride and Cardiovascular Stroke

Article	Year
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial. The American journal of cardiology, 2002, Dec-01, Volume: 90, Issue:11 Topics: Aged; Breast Neoplasms; Coronary Disease; Double-Blind Method; Estrogen Antagonists; Female; Humans; Myocardial Infarction; Patient Selection; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Treatment Outcome	2002

Other Studies

6 other study(ies) available for raloxifene hydrochloride and Cardiovascular Stroke

Article	Year
Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones? Calcified tissue international, 2012, Volume: 90, Issue:1 Topics: Aged; Alendronate; Atherosclerosis; Bone Density Conservation Agents; Calcium; Cohort Studies; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged; Myocardial Infarction; Osteoporosis; Raloxifene Hydrochloride; Retrospective Studies	2012
Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size. European journal of pharmacology, 2003, Apr-25, Volume: 467, Issue:1-3 Topics: Animals; Drug Therapy, Combination; Estrogen Antagonists; Estrogens; Female; Hypercholesterolemia; Medroxyprogesterone; Myocardial Infarction; Necrosis; Ovariectomy; Progesterone Congeners; Rabbits; Raloxifene Hydrochloride	2003
Tamoxifen for prevention of breast cancer. The Medical letter on drugs and therapeutics, 1999, Jan-01, Volume: 41, Issue:1043 Topics: Adult; Breast Neoplasms; Cerebrovascular Disorders; Drug Costs; Endometrial Neoplasms; Estrogen Antagonists; Estrogens; Female; Fractures, Bone; Humans; Middle Aged; Myocardial Infarction; Osteoporosis, Postmenopausal; Piperidines; Placebos; Pulmonary Embolism; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Tamoxifen; Thrombophlebitis	1999
Design and methods of the Raloxifene Use for The Heart (RUTH) study. The American journal of cardiology, 2001, Aug-15, Volume: 88, Issue:4 Topics: Angina, Unstable; Breast Neoplasms; Coronary Disease; Double-Blind Method; Female; Humans; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Research Design; Selective Estrogen Receptor Modulators	2001
[Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart]. Journal of cardiology, 2002, Volume: 39, Issue:1 Topics: Animals; Dogs; Estradiol; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2002
Menopause. HRT: looking for something better. Harvard health letter, 2002, Volume: 27, Issue:7 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Humans; Myocardial Infarction; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2002